181 related articles for article (PubMed ID: 37665633)
21. LncRNA-SNHG16 promotes proliferation and migration of acute myeloid leukemia cells via PTEN/PI3K/AKT axis through suppressing CELF2 protein.
Shi M; Yang R; Lin J; Wei QI; Chen L; Gong W; Li Y; Guo X
J Biosci; 2021; 46():. PubMed ID: 33576342
[TBL] [Abstract][Full Text] [Related]
22. lncRNA TP73-AS1 Regulates miR-21/PTEN Axis to Affect Cell Proliferation in Acute Myeloid Leukemia.
Yuan Z; Li L; Zheng M; Xu J; Wang W
Cancer Biother Radiopharm; 2021 Apr; 36(3):268-272. PubMed ID: 32412786
[No Abstract] [Full Text] [Related]
23. Phosphatase of regenerating liver in hematopoietic stem cells and hematological malignancies.
Kobayashi M; Chen S; Gao R; Bai Y; Zhang ZY; Liu Y
Cell Cycle; 2014; 13(18):2827-35. PubMed ID: 25486470
[TBL] [Abstract][Full Text] [Related]
24. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
[TBL] [Abstract][Full Text] [Related]
25. Targeting the Akt, GSK-3, Bcl-2 axis in acute myeloid leukemia.
Ricciardi MR; Mirabilii S; Licchetta R; Piedimonte M; Tafuri A
Adv Biol Regul; 2017 Aug; 65():36-58. PubMed ID: 28549531
[TBL] [Abstract][Full Text] [Related]
26. [Expression of tumor suppressor gene pten in patients with myelodysplastic syndrome and acute myeloid leukemia].
Zou XL; Liu T; Meng WT; Huang XO
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1086-90. PubMed ID: 18928601
[TBL] [Abstract][Full Text] [Related]
27. PTEN is indispensable for cells to respond to MAPK inhibitors in myeloid leukemia.
Zhang J; Xiang Z; Malaviarachchi PA; Yan Y; Baltz NJ; Emanuel PD; Liu YL
Cell Signal; 2018 Oct; 50():72-79. PubMed ID: 29964149
[TBL] [Abstract][Full Text] [Related]
28. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
[TBL] [Abstract][Full Text] [Related]
29. DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax.
Ye S; Xiong F; He X; Yuan Y; Li D; Ye D; Shi L; Lin Z; Zhao M; Feng S; Zhou B; Weng H; Hong L; Ye H; Gao S
Theranostics; 2023; 13(1):77-94. PubMed ID: 36593968
[No Abstract] [Full Text] [Related]
30. Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia.
Waclawiczek A; Hamilton A; Rouault-Pierre K; Abarrategi A; Albornoz MG; Miraki-Moud F; Bah N; Gribben J; Fitzgibbon J; Taussig D; Bonnet D
J Clin Invest; 2020 Jun; 130(6):3038-3050. PubMed ID: 32364536
[TBL] [Abstract][Full Text] [Related]
31. Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia.
Noguera NI; Song MS; Divona M; Catalano G; Calvo KL; García F; Ottone T; Florenzano F; Faraoni I; Battistini L; Colombo E; Amadori S; Pandolfi PP; Lo-Coco F
Leukemia; 2013 Apr; 27(5):1037-43. PubMed ID: 23183427
[TBL] [Abstract][Full Text] [Related]
32. MN1 and PTEN gene expression in acute myeloid leukemia.
Zayed RA; Eltaweel MA; Botros SK; Zaki MA
Cancer Biomark; 2017; 18(2):177-182. PubMed ID: 27983532
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K/Akt pathway in adult acute leukemia.
Huang FF; Wu DS; Zhang L; Yu YH; Yuan XY; Li WJ; Chen XP; Zhao XL; Chen FP; Zeng H
Cancer Lett; 2013 Aug; 336(1):96-105. PubMed ID: 23603434
[TBL] [Abstract][Full Text] [Related]
34. Alteration of PPAR-GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells.
Esmaeili S; Salari S; Kaveh V; Ghaffari SH; Bashash D
Mol Genet Genomic Med; 2021 Nov; 9(11):e1818. PubMed ID: 34549887
[TBL] [Abstract][Full Text] [Related]
35. PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice.
Peng C; Chen Y; Yang Z; Zhang H; Osterby L; Rosmarin AG; Li S
Blood; 2010 Jan; 115(3):626-35. PubMed ID: 19965668
[TBL] [Abstract][Full Text] [Related]
36. IGF binding protein 2 is a cell-autonomous factor supporting survival and migration of acute leukemia cells.
Chen X; Zheng J; Zou Y; Song C; Hu X; Zhang CC
J Hematol Oncol; 2013 Oct; 6(1):72. PubMed ID: 24191913
[TBL] [Abstract][Full Text] [Related]
37. Altered expression of NEAT1 variants and P53, PTEN, and BCL-2 genes in patients with acute myeloid leukemia.
Rostami M; Kharajo RS; Parsa-Kondelaji M; Ayatollahi H; Sheikhi M; Keramati MR
Leuk Res; 2022 Apr; 115():106807. PubMed ID: 35231756
[TBL] [Abstract][Full Text] [Related]
38. [Dihydroartemisinin Induces AML cell Apoptosis by Inhibition of PTEN/AKT pathway].
An YH; DU J; Hou ZW; Sun WD; Zhou Y; Yu XX; Wang X; Wang Y; Tong XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):88-92. PubMed ID: 32027258
[TBL] [Abstract][Full Text] [Related]
39. PTEN in Regulating Hematopoiesis and Leukemogenesis.
Wu Y; Zhu H; Wu H
Cold Spring Harb Perspect Med; 2020 Oct; 10(10):. PubMed ID: 31712222
[No Abstract] [Full Text] [Related]
40. ROS play an important role in ATPR inducing differentiation and inhibiting proliferation of leukemia cells by regulating the PTEN/PI3K/AKT signaling pathway.
Feng Y; Hua X; Niu R; Du Y; Shi C; Zhou R; Chen FH
Biol Res; 2019 May; 52(1):26. PubMed ID: 31053167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
